Live Breaking News & Updates on Lajos Pusztai

Stay updated with breaking news from Lajos pusztai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New research and treatment advances from Yale Canc

New research and treatment advances from Yale Canc
newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.

United States , Pamela Kunz , Michael Cecchini , Pat Lorusso , Daniel Petrylak , Barbara Burtness , Roy Herbst , Ferrigno Guajardo , Yale Cancer Center , Yale School Of Medicine , American Society Of Clinical Oncology , Yale School , American Society , Clinical Oncology , Cancer Care , From Comfort , Senior Author , Ana Ferrigno Guajardo , Lajos Pusztai ,

New Research and Treatment Advances From Yale Canc

New Research and Treatment Advances From Yale Canc
newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.

United States , Daniel Petrylak , Pat Lorusso , Michael Cecchini , Pamela Kunz , Ferrigno Guajardo , Roy Herbst , Barbara Burtness , Yale School Of Medicine , Yale Cancer Center , American Society Of Clinical Oncology , Yale School , American Society , Clinical Oncology , Cancer Care , From Comfort , Senior Author , Ana Ferrigno Guajardo , Lajos Pusztai ,

Dr Pusztai on the Launch of the DARE Study in ER+/HER2– High-Risk Breast Cancer

Lajos Pusztai, MD, DPhil, discusses the phase 2 DARE trial evaluating circulating tumor DNA-guided second-line adjuvant therapy for patients with high-risk, stage II-III, estrogen receptor-positive, HER2-negative breast cancer, highlighting the importance of researching ctDNA utility in this patient population.
....

San Antonio , United States , Yale Cancer Center , Lajos Pusztai , Medical Oncology , Antonio Breast Cancer Symposium , Onclive Tv ,